WKYMVM

Ac2-26, An Annexin 1 N-Terminal Peptide

Anti-Microbial Peptides

Ac2-26 and WKYMVm

f-MLF analogs

Catalog #	072-01
Standard Size	5 mg
Sequence	Boc - Phe - Leu - Phe - Leu - Phe
M.W	785.51
Mass Spec Analysis	Exhibits correct M.W.
Solubility	Insoluble in water. Soluble in 80% MeOH.
Storage Condition	Store peptide in DRY form at 0-5°C.
Appearance	White powder
Content	The contents of this vial have been accurately determined to contain 5mg of NET peptide.
HPLC Analysis	Purity ≥97%
Additional articles	For best results and reproducibility, rehydrate peptide just before use. Do not refreeze any unused portions.

Please click here or click the reference tab on the top to see more articles that use this product.

Links to publications that use this peptide:

Schepetkin et al. High-Throughput Screening for Small-Molecule Activators of Neutrophils: Identification of Novel N-Formyl Peptide Receptor Agonists
Mol Pharmacol. 2007 Apr;71(4):1061-74.

Bonnans et al. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells.
Biomed Pharmacother. 2007 Jun;61(5):261-7.

Cezar-de-Mello et al. Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly.
Oncogene. 2006 Jan 5;25(1):122-9.

Nascimento-Silva et al. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells.
Am J Physiol Cell Physiol. 2005 Sep;289(3):C557-63.

VanCompernolle et al. Expression and function of formyl peptide receptors on human fibroblast cells.
J Immunol. 2003 Aug 15;171(4):2050-6.

Other Information:

Chemotactic inhibitor - P. H. Naccache et al., Science 203, 461 (1979).

For best results and reproducibility, rehydrate peptide just before use. Do not refreeze any unused portions.